Health Biotchnology Portfolio Fund Price Prediction
| SBHIX Fund | USD 24.22 0.24 1.00% |
Oversold Vs Overbought
63
Oversold | Overbought |
Using Health Biotchnology hype-based prediction, you can estimate the value of Health Biotchnology Portfolio from the perspective of Health Biotchnology response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Health Biotchnology to buy its mutual fund at a price that has no basis in reality. In that case, they are not buying Health because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell mutual funds at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Health Biotchnology after-hype prediction price | USD 24.22 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as fund price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Health |
Health Biotchnology After-Hype Price Prediction Density Analysis
As far as predicting the price of Health Biotchnology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Health Biotchnology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Mutual Fund prices, such as prices of Health Biotchnology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Health Biotchnology Estimiated After-Hype Price Volatility
In the context of predicting Health Biotchnology's mutual fund value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Health Biotchnology's historical news coverage. Health Biotchnology's after-hype downside and upside margins for the prediction period are 23.43 and 25.01, respectively. We have considered Health Biotchnology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Health Biotchnology is very steady at this time. Analysis and calculation of next after-hype price of Health Biotchnology is based on 3 months time horizon.
Health Biotchnology Mutual Fund Price Prediction Analysis
Have you ever been surprised when a price of a Mutual Fund such as Health Biotchnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Health Biotchnology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Fund price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Health Biotchnology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.09 | 0.79 | 0.00 | 0.01 | 0 Events / Month | 0 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
24.22 | 24.22 | 0.00 |
|
Health Biotchnology Hype Timeline
Health Biotchnology is at this time traded for 24.22. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. Health is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at -0.09%. %. The volatility of related hype on Health Biotchnology is about 1247.37%, with the expected price after the next announcement by competition of 24.21. The company last dividend was issued on the 11th of December 1970. Assuming the 90 days horizon the next forecasted press release will be within a week. Check out Health Biotchnology Basic Forecasting Models to cross-verify your projections.Health Biotchnology Related Hype Analysis
Having access to credible news sources related to Health Biotchnology's direct competition is more important than ever and may enhance your ability to predict Health Biotchnology's future price movements. Getting to know how Health Biotchnology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Health Biotchnology may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| DLDCX | Dreyfus Natural Resources | 0.00 | 0 per month | 1.29 | (0.02) | 2.08 | (2.05) | 6.37 | |
| FIKAX | Fidelity Advisor Energy | (0.38) | 2 per month | 1.29 | (0.03) | 2.07 | (2.13) | 5.82 | |
| ALTEX | Firsthand Alternative Energy | 0.00 | 0 per month | 0.00 | (0.12) | 2.83 | (2.74) | 9.14 | |
| ICBAX | Icon Natural Resources | 0.00 | 0 per month | 0.74 | 0.03 | 1.94 | (1.24) | 6.37 | |
| FNCRX | Franklin Natural Resources | 0.00 | 0 per month | 1.03 | (0.04) | 1.60 | (1.81) | 5.15 | |
| SNPIX | Short Oil Gas | 0.00 | 0 per month | 0.00 | (0.20) | 2.04 | (1.71) | 6.81 |
Health Biotchnology Additional Predictive Modules
Most predictive techniques to examine Health price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Health using various technical indicators. When you analyze Health charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Health Biotchnology Predictive Indicators
The successful prediction of Health Biotchnology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Health Biotchnology Portfolio, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Health Biotchnology based on analysis of Health Biotchnology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Health Biotchnology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Health Biotchnology's related companies.
Story Coverage note for Health Biotchnology
The number of cover stories for Health Biotchnology depends on current market conditions and Health Biotchnology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Health Biotchnology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Health Biotchnology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Other Information on Investing in Health Mutual Fund
Health Biotchnology financial ratios help investors to determine whether Health Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Health with respect to the benefits of owning Health Biotchnology security.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |